India  

Covaxin

Vaccine against COVID-19

Covaxin    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Covaxin: Vaccine against COVID-19
Covaxin is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research.

1
shares
ShareTweetSavePostSend
 
PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News [Video]

PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News

Today, the Monsoon session of the Lok Sabha began on a chaotic note with the opposition preventing Prime Minister Narendra Modi from introducing his newly-inducted Union ministers to the House; The..

Credit: Oneindia     Duration: 02:22Published
ISRO plans to launch satellite GISAT-1 on board a GSLV-F10 rocket on August 12 | Oneindia News [Video]

ISRO plans to launch satellite GISAT-1 on board a GSLV-F10 rocket on August 12 | Oneindia News

The Indian Space Research Organisation is getting back into launch activity at Sriharikota spaceport; Today in the afternoon, three militants were killed in an encounter with security forces in..

Credit: Oneindia     Duration: 02:35Published
Covaxin approval: WHO chief scientist says Phase-3 data looks promising| Covid-19| Oneindia News [Video]

Covaxin approval: WHO chief scientist says Phase-3 data looks promising| Covid-19| Oneindia News

WHO Chief Scientist Soumya Swaminathan has said Covaxin's Phase-3 data looks promising and the vaccine can hopefully be approved by the WHO by mid to late August. Senior Advocate Harish Salve on Friday..

Credit: Oneindia     Duration: 02:46Published
Brazil SC gives nod for probe into President Bolsonaro over Covaxin deal| Oneindia News [Video]

Brazil SC gives nod for probe into President Bolsonaro over Covaxin deal| Oneindia News

Trouble mounts for Brazilian President Jair Bolsonaro as Brazil's Supreme Court Justice Rosa Weber late on Friday authorized an investigation of President Jair Bolsonaro in the Covaxin deal with Bharat..

Credit: Oneindia     Duration: 02:00Published
Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News [Video]

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News

Covaxin maker Bharat Biotech has claimed that the vaccine is 77.8% effective overall against Covid-19 after analysing results for its phase 3 trials. Bharat Biotech also claimed that Covaxin provides..

Credit: Oneindia     Duration: 02:13Published
Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News [Video]

Zydus Cadila seeks nod for needle-free, 3-dose vaccine, also tested on teens | Oneindia News

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country's drug regulator for emergency use approval of its COVID-19 vaccine ZyCov-D. An approval for Zydus' vaccine, would make it..

Credit: Oneindia     Duration: 02:09Published
India battles for fair travel regime, tells EU accept our vaccines or...| Oneindia News [Video]

India battles for fair travel regime, tells EU accept our vaccines or...| Oneindia News

In a tit-for tat move, New Delhi has decided to quarntine all European passengers if the European Union does not accept Covaxin or Covishield doses in its digital vaccine passport, reports quoting..

Credit: Oneindia     Duration: 02:00Published
Haryana CM to farmers: We are patient but don't cross limits| Farmer Protest| Oneindia News [Video]

Haryana CM to farmers: We are patient but don't cross limits| Farmer Protest| Oneindia News

Haryana CM said on Wednesday that political leaders have been patient in the face of protests but it won't be good for anyone to cross their limit. An anti-drone system has been installed at the Indian..

Credit: Oneindia     Duration: 02:36Published
Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute| Oneindia News [Video]

Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute| Oneindia News

Studies carried out by the top American health research institute finds that Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), effectively..

Credit: Oneindia     Duration: 02:11Published
Private hospitals’ vaccine orders only via CoWin from July 1; Govt caps vaccine stock |Oneindia News [Video]

Private hospitals’ vaccine orders only via CoWin from July 1; Govt caps vaccine stock |Oneindia News

Yesterday, the government declared that private hospitals must route Covid vaccine orders via the CoWIN app; Today, the Supreme Court ruled that the Centre must pay compensation to the family of those..

Credit: Oneindia     Duration: 02:36Published
Zydus Cadila caps clinical trials of DNA vaccine for minors | Vaccines for children | Oneindia News [Video]

Zydus Cadila caps clinical trials of DNA vaccine for minors | Vaccines for children | Oneindia News

Yesterday, the Centre informed the Supreme Court that Zydus Cadila, which is developing a DNA vaccine, has completed its clinical trials for the 12 to 18 age group. The government added that the Drugs..

Credit: Oneindia     Duration: 01:29Published
Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News [Video]

Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News

Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 according to data from Phase III trials conducted on 25,800 participants across India. The data was submitted to the..

Credit: Oneindia     Duration: 02:03Published
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News [Video]

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was..

Credit: Oneindia     Duration: 02:02Published
New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News [Video]

New born calf serum in Covaxin? Health Ministry corrects facts | Oneindia News

Several social media users including Congress members have been sharing an RTI report that details the "ingredients" used in the India-made Covid-19 vaccine. #Covaxin #CalfSerum #FactCheck

Credit: Oneindia     Duration: 02:00Published
AIIMS study: 'Delta' variant can infect people jabbed with Covishield or Covaxin | Oneindia News [Video]

AIIMS study: 'Delta' variant can infect people jabbed with Covishield or Covaxin | Oneindia News

According to separate studies by AIIMS and the National Centre for Disease Control, the 'delta' variant of COVID-19 is capable of infecting people even after they have received both doses of the..

Credit: Oneindia     Duration: 01:46Published
Vaccine prices at private hospitals capped by centre| Covidshield| Covaxin| Sputnik V| Oneindia News [Video]

Vaccine prices at private hospitals capped by centre| Covidshield| Covaxin| Sputnik V| Oneindia News

A day after Prime Minister Narendra Modi capped the service charge of vaccines administered by private hospitals at Rs 150, the Centre on Tuesday fixed the maximum price for Covid vaccines to be given..

Credit: Oneindia     Duration: 02:04Published
Prime Minister Narendra Modi to address the nation at 5 pm today| Covid-19| Oneindia News [Video]

Prime Minister Narendra Modi to address the nation at 5 pm today| Covid-19| Oneindia News

Covid-19, Coronavirus Pandemic, Covid-19 cases in India, 'Jahan vote, Wahan vaccination', Covidshield, Covaxin, Door to Door vaccination, Pakistan train collision, Pak PM Imran Khan, Ivermectin,..

Credit: Oneindia     Duration: 02:46Published
BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 | Oneindia News [Video]

BJP Minister Prakash Javadekar says India will be fully vaccinated by December 2021 | Oneindia News

Union Minister, BJP, Ministry of Environment, Forest and Climate Change, Ministry of Information and Broadcasting, Ministry of Heavy Industries and Public Enterprises, Congress leader, Congress MP,..

Credit: Oneindia     Duration: 02:01Published

You Might Like


Covaxin trial results on children likely by September: AIIMS chief Randeep Guleria


IndiaTimes - Published

COVID-19 vaccine for children likely by September: AIIMS Chief

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
DNA - Published

Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme

Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
IndiaTimes - Published

AIIMS to begin second dose trial of Bharat Biotech's Covaxin on children between 2-6 years

Not just Bharat Biotech's Covaxin but Zydus Cadila's vaccine for children is also currently under trial in India
DNA - Published

Process to receive WHO pre-qualification for Covaxin under way: Govt


IndiaTimes - Published

Bharat Biotech dossier under review for Covaxin emergency use listing: WHO


IndiaTimes - Published

Government buying Covishield at Rs 215, Covaxin at Rs 225

The fresh vaccine orders placed by the Centre are at a revised price of Rs 215 for Covishield and Rs 225 for a dose of Covaxin, according to an official source. “We are on path to achieving the..
IndiaTimes - Published

Government orders 66 crore vaccine doses worth Rs 14,505 crore

The government is placing its largest order yet of Covid vaccines at 66 crore doses worth Rs 14,505 crore to procure Covishield and Covaxin shots that will help it to substantially meet the vaccine..
IndiaTimes - Published

Ocugen initiates rolling submission to Health Canada for Covaxin


IndiaTimes - Published

Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO


IndiaTimes - Published

WHO Chief Scientist Dr Swaminathan says phase-3 trials of Covaxin look good, Bharat Biotech awaits approval

A few days ago, Bharat Biotech had released the phase 3 clinical trial results of Covaxin after evaluating 130 symptomatic COVID-19 cases.
DNA - Published

Covaxin's overall efficacy 77.8%, 65.2% effective against Delta variant: Bharat Biotech


IndiaTimes - Published

Bharat Biotech says vaccine 93.4% effective against severe Covid-19

Phase-III trials of Covaxin, made by Hyderabad's Bharat Biotech showed it was 93.4% effective against severe symptomatic Covid-19, the firm said on Saturday. The data demonstrated 65.2% protection..
IndiaTimes - Published

Probe Covaxin deal with Brazil: Congress

Congress on Friday demanded that Prime Minister Narendra Modi order an inquiry into the Covaxin deal with Brazil as it focussed on the probe ordered in the recipient country. The party also slammed the..
IndiaTimes - Published

India's request to EU: Consider Covishield, Covaxin under 'Green passport' scheme or face reciprocal policy

Controversy unfolded over EU's move to not include India's Covishield and Covaxin under its 'Green Passport' scheme for its Digital COVID Certificate.
DNA - Published

Brazil suspends Bharat Biotech's Covaxin order for 20m doses

Brazil will suspend a $324-million contract for Covaxin from Bharat Biotech that has mired President Jair Bolsonaro in accusations of irregularities, the health minister said on Tuesday, even as the..
IndiaTimes - Published

Won't recognise your vaccine certificates if you don't include Covaxin, Covishield: India to EU

India will not recognise EU’s digital covid certificate until the EU includes Indian vaccines Covishield and Covaxin in the certificate. ​​In what is certainly the first diplomatic retaliatory..
IndiaTimes - Published

Inching towards WHO's emergency use approval for Covaxin: Bharat Biotech


IndiaTimes - Published

Bharat Biotech slams allegations of wrongdoing in Covaxin procurement deal in Brazil


IndiaTimes - Published

Covaxin effectively neutralises Delta and Alpha variants: Top US body

In yet another booster shot of endorsement for India’s first indigenously developed Covid-19 vaccine Covaxin, the United States’ National Institutes of Health has said that the vaccine is able to..
IndiaTimes - Published

India's Covaxin effectively neutralises Delta variant of Covid, says NIH


IndiaTimes - Published Also reported by •DNA

'Covaxin booster dose can fight variant menace'


IndiaTimes - Published

India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon

India on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the..
IndiaTimes - Published

Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said..
IndiaTimes - Published

India successfully test-fires Agni Prime missile off Odisha coast

Covid-19 cases with variants of concern rose from 10.31 per cent of total infections in May to 51 per cent till June 20, top government officials told a parliamentary panel on Monday and stressed that..
IndiaTimes - Published

Covishield, Covaxin work against SARS-CoV-2's Alpha, Beta, Gamma, Delta variants: Government

Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
IndiaTimes - Published

CM Mamata Banerjee writes to PM Modi, seeks his intervention for early WHO approval for Covaxin

On Wednesday, CM Banerjee also slammed BJP national president JP Nadda for alleging that opposition is playing politics with the vaccination process.
DNA - Published

2-year-old girl from Kanpur Dehat gets Covaxin jab during vaccine trial on children

The toddler, the daughter of a private doctor in Kanpur Dehat, was given the first dose of the indigenous Coronavirus vaccine.
DNA - Published

Make sure Covaxin accepted globally, people facing travel restrictions: Mamata to Centre


IndiaTimes - Published

'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials'

Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources. The Hyderabad-based firm had earlier submitted the trial data to the Subject Expert Committee..
IndiaTimes - Published

Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt sources


IndiaTimes - Published

Shocking! Bihar woman gets both Covaxin, Covishield shots in 5 minutes interval - what happened next, know here

If Devi continues to show no adverse symptoms, she will be tested for antibodies after 14 days, a senior health official at AIIMS Patna has said.
DNA - Published

Covid-19: WHO accepts expression of interest for Covaxin emergency use listing

Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of interest (EoI) for the inactivated..
IndiaTimes - Published

Bharat Biotech, WHO pre-submission meeting on June 23: WHO

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use Listing (EUL) of its indigenous COVID-19..
IndiaTimes - Published

No quarantine for Covishield vaccinated Indians in South Korea, mandatory for Covaxin recipients: Envoy


IndiaTimes - Published

Covaxin does not contain newborn calf serum, say Bharat Biotech and govt


IndiaTimes - Published

Fact Check: No newborn calf serum in Covaxin, Health Ministry and Bharat Biotech confirm

The final vaccine does not contain newborn calf serum at all as the calf serum is not an ingredient of the final vaccine product, Health Ministry said
DNA - Published

Covaxin does not contain newborn calf serum: Centre busts myths

The indigenously developed Covaxin does not contain newborn calf serum, clarified Centre on Wednesday. The statement came in response to some social media posts which the government said have "twisted..
IndiaTimes - Published

SII, Bharat Biotech seek hike in government price for Covid vaccines

Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals..
IndiaTimes - Published

Covaxin average price realisation less than Rs 250 per dose: Bharat Biotech


IndiaTimes - Published

CISF takes over security of Covaxin manufacturer Bharat Biotech's Hyderabad campus


IndiaTimes - Published

Covaxin maker Bharat Biotech gets CISF cover of 64 personnel


IndiaTimes - Published

Can person with any allergy take COVID-19 shots? Know what experts say

Bharat Biotech, the manufacturer of the COVID-19 vaccine said that those who have known allergies to any component of Covaxin should not take the jab.
DNA - Published

Committed to data transparency on Covaxin, published 9 papers in 12 months: Bharat Biotech


IndiaTimes - Published

No US emergency nod coming, Covaxin to seek full approval


IndiaTimes - Published

‘US Covaxin move won’t hit our vax drive’


IndiaTimes - Published

Experts question Covaxin’s high private market price as R&D was govt subsidised

Experts have questioned the rationale of high prices of Covaxin since it is based on an established technology, is domestically-produced, and it’s R&D has been part-subsidised by the Centre. Other..
IndiaTimes - Published

Ocugen to seek emergency nod for Covaxin from Health Canada

Bharat Biotech’s US partner Ocugen said it will be seeking an emergency use nod for India’s first indigenously developed Covid-19 vaccine Covaxin from the Canadian health authorities. The company..
IndiaTimes - Published

Ocugen to seek full approval for Covaxin in US via BLA instead of EUA

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application..
IndiaTimes - Published

Ocugen to take BLA route for Covaxin in US based on FDA recommendation; seek emergency use nod for Canada

Bharat Biotech’s US partner Ocugen has dropped its plans of applying for an emergency use authorisation (EUA) for indigenously developed Covaxin and will be pursuing the biologics license application..
IndiaTimes - Published


 Page 1  〉